Search research articles
Contact Us
Filters
Showing results (151-160 of 180) with videos related to
Page
of 18
Sort By:
The Knee
|
August 13, 2025
History of knee dislocation is associated with longer operative times and higher constraint in total knee arthroplasty: a matched cohort analysis
Benjamin Albertson, Christopher Kurnik, William Curtis, et al.
European Journal of Medicinal Chemistry
|
January 17, 2026
Targeting neuroinflammation by activation of the sigma-1 receptor (S1R) and inhibition of butyrylcholinesterase (hBChE) leads to highly potent anti-amnesic compounds in an Alzheimer's disease mouse model
Kora Reichau, Lucie Crouzier, Tina Gehrig, et al.
Integrative Cancer Therapies
|
April 16, 2015
Sleep Quality Improves During Treatment With Bryophyllum pinnatum: An Observational Study on Cancer Patients
Ana Paula Simões-Wüst, Taziri Al Hassani, Boris Müller-Hübenthal, et al.
Journal of Medicinal Chemistry
|
January 20, 2006
Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist
Barbara Hoefgen, Michael Decker, Patrick Mohr, et al.
Journal of Molecular Biology
|
June 13, 2006
Alzheimer-like plaque formation by human macrophages is reduced by fibrillation inhibitors and lovastatin
Gerald P Gellermann, Kathrin Ullrich, Astrid Tannert, et al.
Angewandte Chemie (International Ed. in English)
|
December 7, 2019
Selective and Wash-Resistant Fluorescent Dihydrocodeinone Derivatives Allow Single-Molecule Imaging of μ-Opioid Receptor Dimerization
Christian Gentzsch, Kerstin Seier, Antonios Drakopoulos, et al.
Journal of Medicinal Chemistry
|
February 6, 2018
Structure-Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles
Dominik Dolles, Matthias Hoffmann, Sandra Gunesch, et al.
European Journal of Medicinal Chemistry
|
May 7, 2011
Mycobacterium tuberculosis and cholinesterase inhibitors from Voacanga globosa
Allan Patrick G Macabeo, Warren S Vidar, Xinyu Chen, et al.
Journal of Medicinal Chemistry
|
May 1, 2023
Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer's Disease Mouse Model
Philipp Spatz, Sophie A M Steinmüller, Anna Tutov, et al.
Biomolecules
|
April 27, 2024
Oxidative Stress Reaction to Hypobaric-Hyperoxic Civilian Flight Conditions
Nikolaus C Netzer, Heidelinde Jaekel, Roland Popp, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 180) with videos related to
Sort By:
Page
of 18
The Knee
|
August 13, 2025
History of knee dislocation is associated with longer operative times and higher constraint in total knee arthroplasty: a matched cohort analysis
Benjamin Albertson, Christopher Kurnik, William Curtis, et al.
European Journal of Medicinal Chemistry
|
January 17, 2026
Targeting neuroinflammation by activation of the sigma-1 receptor (S1R) and inhibition of butyrylcholinesterase (hBChE) leads to highly potent anti-amnesic compounds in an Alzheimer's disease mouse model
Kora Reichau, Lucie Crouzier, Tina Gehrig, et al.
Integrative Cancer Therapies
|
April 16, 2015
Sleep Quality Improves During Treatment With Bryophyllum pinnatum: An Observational Study on Cancer Patients
Ana Paula Simões-Wüst, Taziri Al Hassani, Boris Müller-Hübenthal, et al.
Journal of Medicinal Chemistry
|
January 20, 2006
Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist
Barbara Hoefgen, Michael Decker, Patrick Mohr, et al.
Journal of Molecular Biology
|
June 13, 2006
Alzheimer-like plaque formation by human macrophages is reduced by fibrillation inhibitors and lovastatin
Gerald P Gellermann, Kathrin Ullrich, Astrid Tannert, et al.
Angewandte Chemie (International Ed. in English)
|
December 7, 2019
Selective and Wash-Resistant Fluorescent Dihydrocodeinone Derivatives Allow Single-Molecule Imaging of μ-Opioid Receptor Dimerization
Christian Gentzsch, Kerstin Seier, Antonios Drakopoulos, et al.
Journal of Medicinal Chemistry
|
February 6, 2018
Structure-Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles
Dominik Dolles, Matthias Hoffmann, Sandra Gunesch, et al.
European Journal of Medicinal Chemistry
|
May 7, 2011
Mycobacterium tuberculosis and cholinesterase inhibitors from Voacanga globosa
Allan Patrick G Macabeo, Warren S Vidar, Xinyu Chen, et al.
Journal of Medicinal Chemistry
|
May 1, 2023
Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer's Disease Mouse Model
Philipp Spatz, Sophie A M Steinmüller, Anna Tutov, et al.
Biomolecules
|
April 27, 2024
Oxidative Stress Reaction to Hypobaric-Hyperoxic Civilian Flight Conditions
Nikolaus C Netzer, Heidelinde Jaekel, Roland Popp, et al.
Page
of 18